Annual Global Discovery to Development Innovation Forum Speakers
Christopher J Tame
Senior Principle Scientist
Chris is a medicinal chemist working across Target ID and early discovery chemistry at Benevolent AI. Currently, he is responsible for BenevolentAI’s early discovery chemistry research efforts, and is also drug discovery lead for the BenevolentAI – Astrazeneca collaboration in IPF. Prior to this, Chris spent 10 years as a medicinal chemist at GSK. During this time he contributed to the discovery of clinical candidates for IPF and COPD, as well the pioneering development of PROTAC technology, in collaboration with Craig Crews.